MONTREAL - Montreal researchers have discovered one of the ways developed by cancer cells to resist cancer treatments.
Katherine Borden of the Institute for Research in Immunology and Cancer at the University of Montreal, and his team have identified a previously unknown form of multidrug resistance, glucuronidation of drugs.
"As part of our research, we followed the path by which chemical is desensitization to drugs for up to a protein that regulates the reproduction of genetic information," said Dr. Borden. By disabling this protein, the researchers were able to restore the sensitivity of cancer cells to the drugs.
The researcher said that this process of resistance is not the only one used by the cells, and the process can also be done very quickly, in a few weeks.
However, she says that this discovery opens up promising advances in the fight against cancer.
The results of this work have been published in the scientific journal "Cancer Research".
4 Comments